Correlation Between Bio Path and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Monopar Therapeutics, you can compare the effects of market volatilities on Bio Path and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Monopar Therapeutics.
Diversification Opportunities for Bio Path and Monopar Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bio and Monopar is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Monopar Therapeutics
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bio Path Holdings is 1.14 times less risky than Monopar Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 1,457 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 796.00 from holding Monopar Therapeutics or generate 54.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bio Path Holdings vs. Monopar Therapeutics
Performance |
Timeline |
Bio Path Holdings |
Monopar Therapeutics |
Bio Path and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bio Path and Monopar Therapeutics
The main advantage of trading using opposite Bio Path and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Monopar Therapeutics vs. Cue Biopharma | Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Lantern Pharma | Monopar Therapeutics vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |